HemOnc Today Current Issue

The following articles appeared in the print edition of HemOnc Today.

Table of Contents

• Aspirin’s potential in cancer prevention, treatment remains compelling yet complicated
• Breast, ovarian tumors may share molecular qualities
• Cancer center receives award
• Capsule endoscopy may allow early 
detection of overt lymphoma
• Center appoints faculty members
• Center names physician-in-chief
• Colorectal cancer task force updates colonoscopy surveillance guidelines
• Education could help oncologists better cope with grief
• Patient complications could be mitigated by diagnosis, education
• Patient-led advocacy changed distribution of medical research funding
• Patupilone failed to improve survival in multiple types of gynecologic cancer
• Physician joins research team
• Patients benefit from open access to physicians’ notes
• Predictive biomarker may help guide clinical care for AML patients
• Prone position may be safer during radiation
• SNPs identified for radiation-associated erectile dysfunction
• Surgeon named AANS president
• Warfarin resumption after GI tract bleeding associated with lower thrombosis risk
• FDA approves Abraxane for metastatic NSCLC
• Adjuvant PEG-IFN alfa-2b shows modest RFS benefit in melanoma
• AIDS increases stomach, esophageal cancer risks
• Apixaban appears superior to warfarin across range of patient risk scores
• BCC patients preferred topical treatment vs. surgery
• Cancer-specific anxiety likely increases depressive symptoms
• Cediranib failed to improve FOLFOX/CAPOX survival outcomes
• Cervical HPV increased odds of anal HPV infection in young women
• CXCR4 positivity linked to liver recurrence, poor survival after PAC resection
• Data shed light on recurrence patterns in breast, bowel cancer
• Direct-mail outreach improved odds for colorectal cancer screenings
• Domestic use of bituminous coal linked to lung cancer risk
• Gemcitabine/oxaliplatin treatment effective in patients with advanced HCC
• Gene, pathway mutations identified for treating squamous cell carcinoma
• HCT survivors at increased risk for heart disease
• HIV may explain increase in anal cancer incidence among men
• HPV vaccine linked to syncope, skin infections post-vaccination
• Intermittent androgen deprivation as effective as continuous therapy
• Ketamine offered no clinical benefit in pain management of cancer
• Least aggressive form of breast cancer poses risks years later
• Melanoma mortality risk greater among lymphoma, transplant, HIV/AIDS patients
• NLR may predict HCC recurrence in liver transplant recipients
• Patient navigation reduced delays in breast cancer diagnosis
• Physical activity reduced risk for proximal, distal colon cancer
• PLATO analysis identifies factors contributing to lower mortality with ticagrelor
• Postsurgical complications associated with overweight in gastric cancer patients
• Simple questionnaire may aid in ovarian cancer diagnosis
• Statins unlikely to protect against VTE
• Tanning bed use increased risk for nonmelanoma skin cancer
• White circles, blood spots differentiated SCC from other lesions in dermoscopy
• Ziv-aflibercept yields encouraging results in metastatic colorectal cancer
• Chemoradiotherapy superior to panitumumab-radiotherapy combination
• Off-label TKIs show promise for refractory thyroid cancer
• PCPs chose dermatologists as most qualified for certain procedures